Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Page 1
Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.
Bikdeli B, Caraballo C, Trujillo-Santos J, Galanaud JP, di Micco P, Rosa V, Cusidó GV, Schellong S, Mellado M, Del Valle Morales M, Gavín-Sebastián O, Mazzolai L, Krumholz HM, Monreal M; RIETE Investigators. Bikdeli B, et al. JAMA Cardiol. 2022 Aug 1;7(8):857-865. doi: 10.1001/jamacardio.2022.1988. JAMA Cardiol. 2022. PMID: 35830171 Free PMC article.
IMPORTANCE: Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isolated distal deep vein thrombosis (IDDVT), that is, thrombosis in infrapopliteal veins without proximal extension or pulmonary embolism (PE). …
IMPORTANCE: Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isola …
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study.
Trujillo-Santos J, Farge-Bancel D, Pedrajas JM, Gómez-Cuervo C, Ballaz A, Braester A, Mahé I, Villalobos A, Porras JA, Monreal M; RIETE Investigators. Trujillo-Santos J, et al. Res Pract Thromb Haemost. 2022 Jun 3;6(4):e12736. doi: 10.1002/rth2.12736. eCollection 2022 May. Res Pract Thromb Haemost. 2022. PMID: 35664535 Free PMC article.
OBJECTIVES: The objective of the RIETECAT study was to compare the long-term effectiveness and safety of enoxaparin versus dalteparin or tinzaparin for the secondary prevention of VTE in adults with active cancer. ...
OBJECTIVES: The objective of the RIETECAT study was to compare the long-term effectiveness and safety of enoxaparin versus dalteparin …
Statin use and 30-day mortality in patients with acute symptomatic pulmonary embolism.
Siniscalchi C, Muriel A, Suriñach Caralt JM, Bikdeli B, Jiménez D, Lobo JL, Amado C, Gil-Díaz A, Imbalzano E, Monreal M; the RIETE Investigators. Siniscalchi C, et al. J Thromb Haemost. 2022 Aug;20(8):1839-1851. doi: 10.1111/jth.15753. Epub 2022 May 22. J Thromb Haemost. 2022. PMID: 35510755 Free article.
BACKGROUND: Statins possess antithrombotic and profibrinolytic properties. The association between statin use and short-term outcomes in patients with acute pulmonary embolism (PE) remains unknown. ...
BACKGROUND: Statins possess antithrombotic and profibrinolytic properties. The association between statin use and short-term outcomes …
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE.
Ageno W, Farjat A, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK. Ageno W, et al. Among authors: bounameaux h. Res Pract Thromb Haemost. 2021 Feb 20;5(2):326-341. doi: 10.1002/rth2.12482. eCollection 2021 Feb. Res Pract Thromb Haemost. 2021. PMID: 33733032 Free PMC article.
INTRODUCTION: Venous thromboembolism (VTE) has a long-term risk of recurrence, dependent on the presence or absence of provoking risk factors at the time of the event. ...
INTRODUCTION: Venous thromboembolism (VTE) has a long-term risk of recurrence, dependent on the presence or absence of provoking risk …
Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry.
Riera-Mestre A, Mora-Luján JM, Trujillo-Santos J, Del Toro J, Nieto JA, Pedrajas JM, López-Reyes R, Soler S, Ballaz A, Cerdà P, Monreal M; RIETE Investigators. Riera-Mestre A, et al. Orphanet J Rare Dis. 2019 Aug 9;14(1):196. doi: 10.1186/s13023-019-1172-8. Orphanet J Rare Dis. 2019. PMID: 31399146 Free PMC article.
Most PE and DVT patients received low-molecular-weight heparin for initial (71 and 100%, respectively) and long-term therapy (54 and 67%, respectively). During anticoagulation for VTE, the rate of bleeding events (major 2, non-major 6) far outweighed the rate of VTE recurr …
Most PE and DVT patients received low-molecular-weight heparin for initial (71 and 100%, respectively) and long-term therapy (54 and …
Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry.
Weinberg I, Giri J, Kolluri R, Arcelus JI, Falgá C, Soler S, Braester A, Bascuñana J, Gutiérrez-Guisado J, Monreal M; RIETE Investigators. Weinberg I, et al. J Thromb Thrombolysis. 2018 Nov;46(4):551-558. doi: 10.1007/s11239-018-1736-9. J Thromb Thrombolysis. 2018. PMID: 30196344 Free article.
While our small sample size precludes drawing firm conclusions, this signal should warrant further research into the optimal treatment duration for these patients, as some patients may be at increased risk for long-term recurrence....
While our small sample size precludes drawing firm conclusions, this signal should warrant further research into the optimal treatment durat …
Clinical Prognosis of Nonmassive Central and Noncentral Pulmonary Embolism: A Registry-Based Cohort Study.
Gouin B, Blondon M, Jiménez D, Fernández-Capitán C, Bounameaux H, Soler S, Duce R, Sahuquillo JC, Ruiz-Giménez N, Monreal M; RIETE investigators. Gouin B, et al. Among authors: bounameaux h. Chest. 2017 Apr;151(4):829-837. doi: 10.1016/j.chest.2016.10.056. Epub 2016 Nov 19. Chest. 2017. PMID: 27876590
BACKGROUND: Whether the localization of nonmassive pulmonary embolism (PE) is associated with the short-term and long-term prognosis of patients remains unknown. Our aim was to characterize associations of nonmassive PE localization with risks of recurrent VTE, majo …
BACKGROUND: Whether the localization of nonmassive pulmonary embolism (PE) is associated with the short-term and long-term pro …
Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design.
Weitz JI, Haas S, Ageno W, Angchaisuksiri P, Bounameaux H, Nielsen JD, Goldhaber SZ, Goto S, Kayani G, Mantovani L, Prandoni P, Schellong S, Turpie AG, Kakkar AK. Weitz JI, et al. Among authors: bounameaux h. Thromb Haemost. 2016 Nov 30;116(6):1172-1179. doi: 10.1160/TH16-04-0335. Epub 2016 Sep 22. Thromb Haemost. 2016. PMID: 27656711
VTE management aims to reduce mortality, the risks of recurrence, and long-term complications. VTE treatment is evolving with the introduction of non-vitamin K antagonist anticoagulants (NOACs). ...
VTE management aims to reduce mortality, the risks of recurrence, and long-term complications. VTE treatment is evolving with the int …
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.
Wells PS, Prins MH, Levitan B, Beyer-Westendorf J, Brighton TA, Bounameaux H, Cohen AT, Davidson BL, Prandoni P, Raskob GE, Yuan Z, Katz EG, Gebel M, Lensing AWA. Wells PS, et al. Among authors: bounameaux h. Chest. 2016 Nov;150(5):1059-1068. doi: 10.1016/j.chest.2016.05.023. Epub 2016 Jun 1. Chest. 2016. PMID: 27262225 Clinical Trial.
BACKGROUND: Short-term anticoagulant treatment for acute DVT or pulmonary embolism (PE) effectively reduces the risk of recurrent disease during the first 6 to 12 months of therapy. ...
BACKGROUND: Short-term anticoagulant treatment for acute DVT or pulmonary embolism (PE) effectively reduces the risk of recurrent dis …
DVT Management and Outcome Trends, 2001 to 2014.
Morillo R, Jiménez D, Aibar MÁ, Mastroiacovo D, Wells PS, Sampériz Á, Saraiva de Sousa M, Muriel A, Yusen RD, Monreal M; RIETE investigators. Morillo R, et al. Chest. 2016 Aug;150(2):374-83. doi: 10.1016/j.chest.2016.03.046. Epub 2016 Apr 9. Chest. 2016. PMID: 27071810
BACKGROUND: A comprehensive evaluation of temporal trends in the treatment of patients who have DVT may assist with identification of modifiable factors that contribute to short-term outcomes. METHODS: We assessed temporal trends in length of hospital stay and use of pharm …
BACKGROUND: A comprehensive evaluation of temporal trends in the treatment of patients who have DVT may assist with identification of modifi …
41 results